VirTrial Awarded FDA-Approved Decentralized Clinical Trial with Hope Biosciences
The hybrid decentralized clinical trial (DCT) protocol incorporates remote visits via VirTrial’s telehealth platform. SCOTTSDALE, ARIZ. (PRWEB) OCTOBER 09, 2019 VirTrial has been awarded an FDA-approved hybrid decentralized clinical trial (DCT) with Hope Biosciences. The study provides Hope Biosciences’ autologous, adipose-derived culture-expanded mesenchymal stem cells (HB-adMSC’s) for the treatment of spinal cord injury/disorder[…]
Read more